UIPL members and producers of innovative medicines, in accordance with the Code of Conduct, are committed to public disclosure of the Transfer of Value to healthcare organizations and healthcare workers in Bosnia and Herzegovina.

The main goal of the public announcement of the Transfer of Value is to achieve greater transparency of the relationship between the pharmaceutical industry and health workers/organizations, to preserve and strengthen trust between doctors and pharmaceutical companies, and strengthen the reputation of the pharmaceutical industry and health workers.

Clicking on the company logo or the link below, will take you to the provided ToV Disclosure section that every company and UIPL member is required to publish on their website.

Roche